The Double Blind Study Comparing Disease to Placebo

Abstract
The authors participated in a double blind study on the effectiveness of chymopapain in the treatment of intervertebral disc disease. Results of the double blind study indicated that chymopapain was no more effective than a placebo. The authors challenge the validity of the double blind study because of timing of result evaluation, possible therapeutic activities of the placebo utilized, and possible insufficient dose of chymopapain.

This publication has 0 references indexed in Scilit: